Dr. Koch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
25 Courtenay Dr
Charleston, SC 29425Phone+1 843-792-6982
Education & Training
- Medical University of South CarolinaFellowship, Gastroenterology, 2004 - 2007
- University of Alabama Medical CenterResidency, Internal Medicine, 2001 - 2004
- Louisiana State University School of Medicine in New OrleansClass of 2001
Certifications & Licensure
- ME State Medical License 2020 - 2025
- SC State Medical License 2004 - 2025
- AL State Medical License 2002 - 2004
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- 1 citationsObjective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.Andrew D Schreiner, Jingwen Zhang, William P Moran, David G Koch, Justin Marsden
Endocrine Practice. 2024-11-01 - FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.Andrew D Schreiner, Jingwen Zhang, William P Moran, David G Koch, Justin Marsden
Journal of Clinical Gastroenterology. 2024-10-01 - H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.David G Koch, Don C Rockey, Sheldon S Litwin, Ryan J Tedford
Digestive Diseases and Sciences. 2024-08-01
Journal Articles
- Use of Intra‐Aortic Counterpulsation in Cardiogenic Shock Post‐Liver TransplantationGabriel R Chedister, William D Stoll, Kenneth D Chavin, John W McGillicuddy, Satish N Nadig, David G Koch, Clinical Transplantation
Press Mentions
- First Edition: April 23, 2020April 23rd, 2020
Grant Support
- Novel Mechanisms of Hepatopulmonary SyndromeNIH/NHLBI2018–2024
- TARGET-HCC: A Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular CarcinomaTARGET-RWE2016–2024
- TARGET-NASH: A 5-year, Longitudinal, Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisTARGET-RWE2016–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: